Eli Lilly plans to turn India into a growth market by addressing its diabetes and obesity challenges with its new treatment, Mounjaro. CEO David Ricks...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - Times of India - Top Stories - 20/Mar 10:51
Ozempic-like weight loss drug Mounjaro launched in India - Details
Eli Lilly has launched Mounjaro in India, a new once-weekly injectable drug for type 2 diabetes and weight management. Approved by CDSCO, it targets GIP and GLP-1 receptors, aiming to improve blood sugar control and aid in weight loss. Clinical trials showed significant results, underlining its potential in treating diabetes and obesity.
Articles similaires
'Goal is to offer more innovative medicines'
times of india - 26/Mar 00:53
Eli Lilly plans to turn India into a growth market by addressing its diabetes and obesity challenges with its new treatment, Mounjaro. CEO David Ricks...
Weight-loss drugs like Ozempic can prevent heart disease, study finds
knowridge.com - 28/Mar 15:05
Losing weight is a common New Year’s resolution, and many people are now turning to advanced weight-loss medications like Ozempic for help. These...
Novo Nordisk To Pay $2 Billion for New Weight Loss Drug
drugs.com - 25/Mar 16:03
TUESDAY, March 25, 2025 -- Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new...
Novo Nordisk To Pay $2 Billion for New Weight Loss Drug
drugs.com - 25/Mar 16:03
TUESDAY, March 25, 2025 -- Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new...
Diabetes Alters Memory and Reward Processing: A New Understanding
medindia.net - 26/Mar 21:35
Study reveals how diabetes rewires the brain, affecting memory and reward processing by linking high blood sugar to changes in the anterior...
Weight-loss drug Wegovy now available in Ireland
thejournal.ie - 24/Mar 10:54
Work is continuing so that the drug, and similar medicines, can be issued under medical card schemes to slash costs.
Type 2 diabetes can be reversed — Here’s how
knowridge.com - 24/Mar 10:17
More than 36 million Americans are currently living with type 2 diabetes, a chronic condition where the body doesn’t respond properly to insulin,...
Type 2 diabetes can be reversed — Here’s how
knowridge.com - 24/Mar 10:17
More than 36 million Americans are currently living with type 2 diabetes, a chronic condition where the body doesn’t respond properly to insulin,...
Les derniers communiqués
-
Aucun élément